Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Kayoko Hayakawa

Showing results (1-10 of 245) with videos related to

Pageof 25
Sort By:
The Lancet. Global Health|August 15, 2018
Estimating the impact of antimicrobial resistanceNobuaki Matsunaga, Kayoko Hayakawa
The New England Journal of Medicine|August 9, 2013
Images in clinical medicine. Rubella rashSatoshi Kutsuna, Kayoko Hayakawa
Global Health & Medicine|January 2, 2023
Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in JapanKohei Kamegai, Kayoko Hayakawa
Infection|October 19, 2016
Minocycline-induced skin pigmentationTetsuro Kobayashi, Kayoko Hayakawa
Internal Medicine (Tokyo, Japan)|November 5, 2014
Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD)Kei Yamamoto, Kayoko Hayakawa, Norio Ohmagari
Journal of Travel Medicine|March 21, 2016
A 41-year-old man with fever and dark-coloured urineTetsuro Kobayashi, Kayoko Hayakawa, Yasuyuki Kato
Internal Medicine (Tokyo, Japan)|January 17, 2014
Scarlet fever in an adultSatoshi Kutsuna, Kayoko Hayakawa, Norio Ohmagari
Global Health & Medicine|May 19, 2022
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in JapanHidetoshi Nomoto, Kayoko Hayakawa, Norio Ohmagari
The American Journal of the Medical Sciences|April 6, 2012
Fever of unknown origin: an evidence-based reviewKayoko Hayakawa, Balaji Ramasamy, Pranatharthi H Chandrasekar
Global Health & Medicine|March 7, 2024
Bloodstream infections in the elderly Japanese population: Current reality and countermeasuresKeiji Nakamura, Kayoko Hayakawa, Shinya Tsuzuki, et al.
Pageof 25

Showing results (1-10 of 245) with videos related to

Sort By:
Pageof 25
The Lancet. Global Health|August 15, 2018
Estimating the impact of antimicrobial resistanceNobuaki Matsunaga, Kayoko Hayakawa
The New England Journal of Medicine|August 9, 2013
Images in clinical medicine. Rubella rashSatoshi Kutsuna, Kayoko Hayakawa
Global Health & Medicine|January 2, 2023
Towards the light at the end of the tunnel: Changes in clinical settings and political measures regarding COVID-19 from 2021, and future perspectives in JapanKohei Kamegai, Kayoko Hayakawa
Infection|October 19, 2016
Minocycline-induced skin pigmentationTetsuro Kobayashi, Kayoko Hayakawa
Internal Medicine (Tokyo, Japan)|November 5, 2014
Daptomycin-induced pneumonitis in a patient with chronic obstructive pulmonary disease (COPD)Kei Yamamoto, Kayoko Hayakawa, Norio Ohmagari
Journal of Travel Medicine|March 21, 2016
A 41-year-old man with fever and dark-coloured urineTetsuro Kobayashi, Kayoko Hayakawa, Yasuyuki Kato
Internal Medicine (Tokyo, Japan)|January 17, 2014
Scarlet fever in an adultSatoshi Kutsuna, Kayoko Hayakawa, Norio Ohmagari
Global Health & Medicine|May 19, 2022
Impact of prioritized vaccinations for the elderly on the COVID-19 pandemic in JapanHidetoshi Nomoto, Kayoko Hayakawa, Norio Ohmagari
The American Journal of the Medical Sciences|April 6, 2012
Fever of unknown origin: an evidence-based reviewKayoko Hayakawa, Balaji Ramasamy, Pranatharthi H Chandrasekar
Global Health & Medicine|March 7, 2024
Bloodstream infections in the elderly Japanese population: Current reality and countermeasuresKeiji Nakamura, Kayoko Hayakawa, Shinya Tsuzuki, et al.
Pageof 25